Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Jan 2000

Saelue Pirun, Sinthujaroen Patuma, Suwiwat Supaporn, Thongsuksai Paramee

Abstract excerpt

INTRODUCTION: Essential thrombocythemia (ET) involves the proliferation of megakaryocytes and platelets and is associated with an increased risk of thrombosis. We aimed to evaluate thrombotic risks in patients with epigenetic regulator mutations and generate a model to predict thrombosis in ET. MATERIALS AND METHODS: This cohort study enrolled patients aged > 15 years diagnosed with ET at the Songklanakarind...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Recurrence

Share to Survival Analysis

Share to Thrombocythemia, Essential

Share to Thrombosis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39053144
DOI: 10.1177/10760296241263099
PMCID: PMC11282546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.PMID 39053144Read ↗

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Essential Thrombocythemia: One-Center Data in a Changing Disease.Semantic proximity Read ↗

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.Semantic proximity Read ↗

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.Semantic proximity Read ↗

Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.Semantic proximity Read ↗

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.Semantic proximity Read ↗

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.Semantic proximity Read ↗

The Roles of Genetic and Epigenetic Abnormalities in Essential ThrombocythemiaSemantic proximity Read ↗

Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China.Semantic proximity Read ↗

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.Semantic proximity Read ↗

Essential thrombocythemia treatment algorithm 2018.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.